ZENTHLINE

Indications

• Bacterial infections
• Pneumonia
• Urinary tract infections
• Skin infections
• Sepsis
• Meningitis

Dosage

Children: Dosage varies by specific antibiotic and infection type. Refer to the BNF for Children for appropriate dosing.

Adults: Dosage varies by specific antibiotic and infection type. Refer to the prescribing information for each antibiotic.

Mechanism of action

Bacteria can have various mechanisms of action depending on the species. Pathogenic bacteria often produce virulence factors that help them invade host tissues, evade the immune system, and acquire nutrients. Common mechanisms include the secretion of toxins, adhesion to host cells, and the formation of biofilms. Antibiotics target specific bacterial functions, such as cell wall synthesis or protein synthesis, which can inhibit bacterial growth or kill the bacteria.

Pharmacodynamics

The pharmacodynamics of antibiotics against bacteria involve the relationship between drug concentration and the resulting effect on bacterial growth and survival. This includes the minimum inhibitory concentration (MIC), which is the lowest concentration of an antibiotic that prevents visible growth of bacteria. Antibiotics can exhibit bactericidal effects, killing bacteria, or bacteriostatic effects, inhibiting their growth. The efficacy of antibiotics can be influenced by factors such as bacterial resistance mechanisms, the site of infection, and the host's immune response.

Pharmacokinetics

Pharmacokinetics of antibiotics refers to the absorption, distribution, metabolism, and excretion of the drugs used to treat bacterial infections. Factors such as the route of administration (oral, intravenous, intramuscular), bioavailability, volume of distribution, and half-life determine how effectively an antibiotic reaches the site of infection. Some antibiotics may require dose adjustments based on renal or hepatic function. The presence of protein binding can also affect the free concentration of the drug available for action against bacteria.

Pregnancy

Consult a healthcare professional for advice on the use of antibiotics during pregnancy, as some may pose risks to fetal development.

Breast-feeding

Consult a healthcare professional before using antibiotics while breastfeeding, as some may pass into breast milk and affect the infant.

Storage

Store in a cool, dry place away from direct sunlight. Ensure that medications are kept out of reach of children.

Indications

• Bacterial infections
• Pneumonia
• Meningitis
• Syphilis
• Endocarditis
• Skin and soft tissue infections

Dosage

Children: Paediatric dosing for benzylpenicillin is determined by the child's weight and the severity of the infection. Refer to the BNF for Children for specific dosing guidelines.

Adults: The usual adult dose for benzylpenicillin varies based on the type and severity of the infection. It is generally administered via intramuscular or intravenous routes. For severe infections, doses may range from 1 to 4 million units every 4 to 6 hours.

Mechanism of action

Benzylpenicillin exerts its antibacterial effects by inhibiting the synthesis of bacterial cell walls. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, disrupting the transpeptidation process, which is crucial for cross-linking peptidoglycan layers. This inhibition leads to cell lysis and death of the bacteria.

Pharmacodynamics

Benzylpenicillin demonstrates time-dependent bactericidal activity, meaning its effectiveness is related to the duration of time the drug concentration remains above the minimum inhibitory concentration (MIC) for the target bacteria. It has a narrow spectrum of activity, primarily targeting Gram-positive cocci and some Gram-negative rods.

Pharmacokinetics

Benzylpenicillin is typically administered parenterally due to poor oral absorption. It is rapidly distributed throughout the body and can penetrate various tissues, including the central nervous system during inflammation. The drug is primarily eliminated by renal excretion, with a half-life of approximately 30 minutes to 1 hour in healthy individuals. Dosage adjustments may be necessary in patients with renal impairment.

Interactions

• leflunomide+benzylpenicillin: Unknown (increases exposure)
• nitisinone+benzylpenicillin: Unknown (increases exposure)
• teriflunomide+benzylpenicillin: Unknown (increases exposure)

Pregnancy

Benzylpenicillin is generally considered safe to use during pregnancy, as it is a penicillin antibiotic and has a long history of use.

Breast-feeding

Benzylpenicillin is excreted in breast milk in small amounts, but it is not expected to have adverse effects on a nursing infant.

Storage

Store in a cool, dry place, protected from light. Reconstituted solutions should be used promptly or stored in a refrigerator and used within a limited time frame.

Formulations

• Benzylpenicillin injection

Indications

• Anemia
• Hemorrhage
• Infection
• Coagulation disorders
• Transfusion needs

Dosage

Children: Pediatric dosing for blood products also varies by indication and patient condition. Consult pediatric dosing guidelines for specific recommendations.

Adults: Dosage for blood products varies based on the indication, type of product (e.g., packed red blood cells, plasma), and patient condition. Refer to specific guidelines based on clinical context.

Mechanism of action

Blood functions through various components: red blood cells (erythrocytes) transport oxygen via hemoglobin, white blood cells (leukocytes) are integral to the immune response, and platelets (thrombocytes) are crucial for clotting. Plasma, the liquid portion, carries nutrients, hormones, and proteins throughout the body.

Pharmacodynamics

Blood's pharmacodynamics are influenced by its components. Erythrocytes carry oxygen from the lungs to tissues and return carbon dioxide to be exhaled. Leukocytes respond to infections and foreign bodies, while platelets aggregate at injury sites, initiating the clotting cascade. Blood also regulates body temperature, pH levels, and fluid balance, contributing to homeostasis.

Pharmacokinetics

Blood volume and composition can vary by individual, but the average adult has about 5-6 liters of blood. Erythrocytes have a lifespan of approximately 120 days, while leukocytes and platelets have shorter lifespans. Blood components are continuously produced in the bone marrow, and their levels are regulated by various factors, including hormonal signals.

Adverse effects

• Hemolysis
• Allergic reactions
• Infection
• Transfusion reactions
• Iron overload
• Graft-versus-host disease

Interactions

• Anticoagulants (e.g., warfarin, heparin) may increase bleeding risk
• Certain antibiotics may interact with blood components
• Immunosuppressants can affect the immune response to transfusions

Precautions

• Monitor for signs of transfusion reactions
• Ensure compatibility of blood products
• Use with caution in patients with a history of transfusion reactions

Pregnancy

Blood transfusions may be necessary during pregnancy for conditions such as severe anemia or hemorrhage. The risks and benefits should be assessed carefully.

Breast-feeding

Blood transfusions are not contraindicated during breastfeeding. However, mothers should be monitored for any adverse effects post-transfusion.

Storage

Blood products should be stored in a controlled temperature environment, typically between 1°C and 6°C for red blood cells, and must be used within specified time limits after collection.

Formulations

• Whole blood
• Red blood cells
• Platelets
• Plasma
• Cryoprecipitate

Indications

• Carbuncle
• Boil
• Skin abscess
• Furunculosis

Dosage

Children: Refer to the specific antibiotic's prescribing information based on local guidelines and susceptibility patterns.

Adults: Refer to the specific antibiotic's prescribing information based on local guidelines and susceptibility patterns.

Mechanism of action

Carbuncle treatment often involves antibiotics which work by inhibiting bacterial cell wall synthesis or protein synthesis. Common antibiotics include penicillins, cephalosporins, and clindamycin, which target specific bacterial pathways, leading to bacterial cell death.

Pharmacodynamics

The pharmacodynamics of antibiotics used to treat carbuncles include the disruption of bacterial cell wall integrity and interference with metabolic processes, ultimately resulting in bactericidal or bacteriostatic effects. The choice of antibiotic may depend on the susceptibility of the bacteria involved.

Pharmacokinetics

Pharmacokinetics varies by the specific antibiotic used. Generally, these agents are absorbed through the gastrointestinal tract, distributed throughout the body, metabolized by the liver, and excreted primarily via the kidneys. The half-life, peak plasma concentrations, and tissue penetration are critical factors in determining dosing regimens.

Contra-indications

• Hypersensitivity to carbuncie or any of its components
• Severe renal impairment
• Severe hepatic impairment

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Dizziness
• Headache
• Rash
• Fatigue

Interactions

• Anticoagulants
• Antiepileptics
• Other medications that affect liver enzymes

Precautions

• Use with caution in patients with a history of liver disease
• Monitor renal function during therapy
• Assess for potential drug interactions

Pregnancy

Carbuncie is not recommended during pregnancy unless clearly needed, as safety has not been established.

Breast-feeding

Use caution when administering to breastfeeding mothers; consult healthcare provider.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

• Tablets
• Oral suspension
• Injectable solution

Dosage

Children: Refer to relevant clinical guidelines or drug references for appropriate dosing.

Adults: Refer to relevant clinical guidelines or drug references for appropriate dosing.

Pregnancy

There are no well-controlled studies in pregnant women. The potential benefits must be weighed against the potential risks.

Breast-feeding

It is not known whether caused is excreted in human milk. Caution should be exercised when administered to a nursing woman.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Therapeutic drug monitoring
• Determining dosing regimens
• Assessing drug interactions
• Evaluating toxicity
• Guiding clinical decision-making

Dosage

Children: Dosage should be determined based on the specific drug, condition being treated, and individual patient factors. Refer to appropriate clinical guidelines or pharmacology references for exact dosing information.

Adults: Dosage should be determined based on the specific drug, condition being treated, and individual patient factors. Refer to appropriate clinical guidelines or pharmacology references for exact dosing information.

Mechanism of action

Concentration determines pharmacological effects by influencing the binding of drugs to their target receptors, enzymes, or transporters. Higher concentrations typically increase the likelihood of binding, enhancing the drug's therapeutic action. Conversely, excessive concentrations can lead to toxicity and adverse reactions due to non-specific interactions.

Pharmacodynamics

Pharmacodynamics relates to the relationship between drug concentration and effect. The dose-response relationship often follows a sigmoid curve, where increasing concentrations lead to progressively greater effects until a plateau is reached. Understanding this relationship is crucial for optimizing drug therapy, as it informs clinicians about the appropriate dosing to achieve desired therapeutic outcomes while minimizing toxicity.

Pharmacokinetics

Pharmacokinetics involves the study of how concentrations of a drug change over time within the body, encompassing absorption, distribution, metabolism, and excretion (ADME). Factors such as bioavailability, volume of distribution, clearance rates, and half-life are essential for determining how long a drug remains effective and at what concentration. Variability in these parameters can arise from patient-specific factors such as age, weight, organ function, and genetic differences.

Pregnancy

Concentrations should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult with a healthcare provider for individual assessment.

Breast-feeding

It is unknown whether concentrations are excreted in human milk. Caution should be exercised when administering to breastfeeding mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Indications

• Cystathionine beta-synthase deficiency
• Hyperhomocysteinemia

Dosage

Children: Refer to specific clinical guidelines or pharmacy references for detailed dosing information.

Adults: Refer to specific clinical guidelines or pharmacy references for detailed dosing information.

Mechanism of action

Crysiplas works by catalyzing the condensation of homocysteine and serine to form cystathionine. This process is facilitated by the enzyme cystathionine beta-synthase, which is deficient in patients with cystathionine beta-synthase deficiency. By enhancing the metabolism of homocysteine, crysiplas effectively reduces its plasma concentration and alleviates the toxic effects associated with elevated levels.

Pharmacodynamics

The pharmacodynamics of crysiplas involve its ability to lower plasma homocysteine levels and restore metabolic balance in individuals with cystathionine beta-synthase deficiency. The reduction of homocysteine is essential in preventing the long-term complications associated with its accumulation, including vascular damage and organ dysfunction. Crysiplas may improve quality of life and reduce the risk of cardiovascular events in affected patients.

Pharmacokinetics

Crysiplas is administered intravenously and has a bioavailability that allows for rapid onset of action. The pharmacokinetics profile indicates that it is distributed widely in the body, with a half-life that supports regular dosing schedules. The metabolism of crysiplas is primarily through enzymatic pathways, and it is excreted via the kidneys. The exact parameters of its absorption, distribution, metabolism, and excretion (ADME) can vary based on individual patient factors.

Adverse effects

• Headache
• Nausea
• Vomiting
• Diarrhea
• Fatigue
• Dizziness

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of hypersensitivity
• Use cautiously in patients with pre-existing cardiac conditions

Pregnancy

Crysiplas should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is essential to consult healthcare professionals before use.

Breast-feeding

Crysiplas is excreted in breast milk. Caution is advised when administering to nursing mothers, and healthcare professionals should be consulted.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

• Injectable solution
• Oral tablets

Indications

• Fever of various etiologies
• Infection
• Inflammation
• Viral illnesses
• Postoperative recovery

Dosage

Children: Refer to the BNF for Children for appropriate dosing based on age and weight.

Adults: Refer to specific antipyretic guidelines in the BNF, as dosing can vary depending on the medication used.

Mechanism of action

Fever often results from the release of pyrogens, which are substances that induce fever. These pyrogens stimulate the hypothalamus to increase the body's temperature set point. Antipyretics, such as paracetamol, inhibit the enzyme cyclooxygenase (COX), leading to a decrease in prostaglandin synthesis, which in turn lowers the elevated temperature by promoting heat dissipation.

Pharmacodynamics

Antipyretics exert their effects by acting on the hypothalamus to reset the body's temperature regulation. They work to reduce fever by enhancing heat loss from the body (through processes such as vasodilation and sweating) and inhibiting the production of fever-inducing substances. The onset of action for oral antipyretics is typically within 30 minutes to an hour.

Pharmacokinetics

The pharmacokinetics of antipyretic agents like paracetamol involve rapid absorption from the gastrointestinal tract, with peak plasma concentrations occurring within 30 minutes to 2 hours after ingestion. It is metabolized primarily in the liver and has a half-life of about 2 to 3 hours in healthy individuals. Elimination is primarily via renal excretion, with a small fraction excreted unchanged.

Pregnancy

Consult healthcare provider before use. Some antipyretics may be deemed safe, while others may not be recommended during pregnancy.

Breast-feeding

Consult healthcare provider before use. Many antipyretics are generally considered safe during breastfeeding.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Furuncles
• Boils
• Skin abscesses
• Staphylococcal infections

Dosage

Children: Refer to the respective antibiotic guidelines for specific dosing recommendations based on the child's age, weight, and severity of the infection.

Adults: Refer to the respective antibiotic guidelines for specific dosing recommendations based on the severity of the infection and patient characteristics.

Mechanism of action

Furuncles are primarily caused by the infection of hair follicles with bacteria, leading to inflammation and pus formation. Antibiotics used in the treatment target the bacterial cell wall synthesis, protein synthesis, or metabolic pathways, leading to bacterial cell death or inhibition of growth.

Pharmacodynamics

Antibiotics used to treat furuncles, such as penicillins or cephalosporins, work by inhibiting the synthesis of bacterial cell walls, which is essential for bacterial survival. This leads to cell lysis and death of the bacteria. The inflammatory response is also modulated, reducing pain and swelling associated with the infection.

Pharmacokinetics

The pharmacokinetics of antibiotics can vary significantly based on the specific drug used. Generally, these drugs are absorbed in the gastrointestinal tract, distributed widely throughout body tissues, and metabolized primarily by the liver. Renal excretion is a common pathway for the elimination of these drugs. Peak plasma concentrations are typically reached within a few hours after oral administration, and the half-life can range from a few hours to a day, depending on the specific antibiotic.

Adverse effects

• Skin irritation
• Allergic reactions
• Hypersensitivity
• Local pain or discomfort

Precautions

• Use cautiously in patients with a history of allergic reactions to topical agents.
• Monitor for signs of local infection or worsening of symptoms.

Pregnancy

Not enough data to establish safety in pregnancy, consult a healthcare professional.

Breast-feeding

Consult a healthcare professional before use, as safety is not established.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Topical ointments
• Creams
• Gels

Dosage

Children: Refer to specific drug information for dosing guidelines.

Adults: Refer to specific drug information for dosing guidelines.

Pregnancy

Consult a healthcare provider for advice on use during pregnancy, as the safety of this medication may not be established.

Breast-feeding

Consult a healthcare provider before use while breastfeeding, as the drug may pass into breast milk.

Storage

Store in a cool, dry place away from light and moisture, and keep out of reach of children.

Dosage

Children: Refer to specific drug guidelines for dosing.

Adults: Refer to specific drug guidelines for dosing.

Pregnancy

Consult a healthcare professional before use, as safety during pregnancy has not been established.

Breast-feeding

Consult a healthcare professional before use, as safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Pregnancy

Consult a healthcare professional before use. Risks vs benefits should be evaluated.

Breast-feeding

Consult a healthcare professional before use. Risks vs benefits should be evaluated.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Bacterial infections
• Viral infections
• Fungal infections
• Parasitic infections
• Sepsis
• Pneumonia
• Urinary tract infections
• Skin and soft tissue infections
• Gastrointestinal infections

Dosage

Children: Refer to BNF for Children and

Adults: Refer to appropriate antimicrobial guidelines and specific drug BNF entries for dosing.

Mechanism of action

Antimicrobial agents function through various mechanisms depending on their class. Bactericidal agents kill bacteria directly, while bacteriostatic agents inhibit bacterial growth. Common mechanisms include inhibition of cell wall synthesis (e.g., penicillins), disruption of nucleic acid synthesis (e.g., fluoroquinolones), interference with protein synthesis (e.g., aminoglycosides), and alteration of cell membrane permeability (e.g., polymyxins). Antiviral agents may inhibit viral entry, replication, or assembly. Antifungal agents disrupt fungal cell membranes or inhibit synthesis of essential components like ergosterol.

Pharmacodynamics

Antimicrobial agents exhibit concentration-dependent or time-dependent killing effects. Their efficacy can be influenced by the site of infection, the immune response of the host, and the presence of resistant strains. The minimum inhibitory concentration (MIC) is a critical parameter that helps determine the appropriate dosing regimen for effective treatment. Adverse effects can include toxicity to host cells, disruption of normal flora, and allergic reactions.

Pharmacokinetics

Pharmacokinetics of antimicrobial agents encompass absorption, distribution, metabolism, and excretion (ADME). Most antibiotics are absorbed in the gastrointestinal tract, though some may require intravenous administration for systemic infections. Distribution varies, with some agents achieving higher concentrations in certain tissues or fluids (e.g., cerebrospinal fluid, lung tissue). Metabolism often occurs in the liver, with various pathways leading to active or inactive metabolites. Renal excretion is common, necessitating dose adjustments in patients with renal impairment.

Adverse effects

• Nausea
• Diarrhea
• Allergic reactions
• Rash
• Dizziness
• Headache

Interactions

• May interact with anticoagulants, increasing the risk of bleeding
• Can interact with certain antiretrovirals, affecting their efficacy
• Potential interaction with cytochrome P450 substrates

Precautions

• Use with caution in patients with renal impairment
• Monitor liver function in patients with liver disease
• Assess for potential allergic reactions in patients with a history of drug allergies

Pregnancy

Considered safe in pregnancy for certain infections, but risk-benefit analysis is required.

Breast-feeding

Generally safe, but consult a healthcare professional for specific medications.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Tablets
• Capsules
• Suspensions
• Injectables

Indications

• Mild pain relief
• Mild inflammation
• Fever reduction
• Mild respiratory infections

Dosage

Children: Refer to specific drug guidelines as paediatric doses must be adjusted based on weight and age.

Adults: Refer to specific drug guidelines as doses can vary widely based on the drug class and formulation.

Mechanism of action

Mild drugs generally act by inhibiting specific enzymes, modulating receptor activity, or affecting neurotransmitter levels in the body. For example, mild analgesics like paracetamol work by inhibiting the synthesis of prostaglandins in the central nervous system, while others may act on peripheral nerve endings to alleviate discomfort.

Pharmacodynamics

The pharmacodynamics of mild drugs involve their interaction with biological receptors or pathways that lead to therapeutic effects. For instance, the analgesic effect may result from the modulation of pain perception pathways in the central nervous system. The onset of action and maximum effect can vary depending on the specific drug class, but mild drugs typically provide relief without producing significant sedation or other central nervous system effects.

Pharmacokinetics

The pharmacokinetics of mild drugs include absorption, distribution, metabolism, and excretion. These drugs are often well-absorbed from the gastrointestinal tract and may have a rapid onset of action. They are usually metabolized in the liver and excreted via the kidneys. The half-life can vary significantly among different mild drugs, influencing dosing frequency and duration of action.

Pregnancy

Use with caution. Consult a healthcare provider for risk assessment.

Breast-feeding

Consult a healthcare provider, as safety during breastfeeding is not well established.

Storage

Store at room temperature, away from moisture and heat.

Indications

• Contraception
• Regulation of menstrual cycles
• Management of menstrual disorders
• Treatment of premenstrual syndrome (PMS)
• Acne treatment in females of reproductive age

Dosage

Children: There are no specific pediatric dosing recommendations; consult relevant clinical guidelines for use in adolescents.

Adults: Dosage is individualized based on clinical indication and patient needs; refer to specific guidelines for dosing regimens.

Mechanism of action

Only works primarily by inhibiting ovulation through the suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion from the pituitary gland. This leads to reduced ovarian follicular development and ovulation. Additionally, the progestin component thickens the cervical mucus, which impedes sperm passage, and alters the endometrium, making it less suitable for implantation.

Pharmacodynamics

The pharmacodynamics of Only involve the modulation of estrogen and progestin receptors, leading to changes in the reproductive system. The drug's active components induce changes in the hypothalamic-pituitary-ovarian axis, resulting in decreased gonadotropin levels and preventing ovulation. The hormonal changes also impact the menstrual cycle, helping to regulate irregularities and alleviate symptoms of premenstrual syndrome (PMS).

Pharmacokinetics

After oral administration, Only is rapidly absorbed, with peak plasma concentrations occurring within 1 to 3 hours. The bioavailability of the drug is influenced by first-pass metabolism in the liver. The active components are extensively bound to plasma proteins, primarily albumin and sex hormone-binding globulin (SHBG). The elimination half-life varies, with norgestimate being metabolized to its active form, and both components being primarily excreted in urine as metabolites. Steady-state concentrations are typically achieved after several days of consistent dosing.

Pregnancy

Safety during pregnancy has not been established. Consult a healthcare provider before use.

Breast-feeding

Consult a healthcare provider before use while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight and moisture.

Indications

• Anxiety disorders
• Depression
• Obsessive-compulsive disorder
• Post-traumatic stress disorder
• Chronic pain management

Dosage

Children: Refer to the BNF for Children for appropriate dosing information in paediatric patients.

Adults: Refer to the BNF for specific dosing guidelines based on the condition being treated.

Mechanism of action

Peak functions primarily as a selective inhibitor of specific enzymes and pathways involved in cellular signaling. It modulates receptor activity and alters neurotransmitter levels, leading to its therapeutic effects in various conditions.

Pharmacodynamics

The pharmacodynamics of Peak involve its interaction with target receptors and enzymes that play a crucial role in physiological processes. By inhibiting these targets, Peak can lead to alterations in cellular responses, thus providing clinical benefits in the treatment of specified conditions.

Pharmacokinetics

Peak is absorbed following oral administration, with peak plasma concentrations achieved within a defined timeframe. It is metabolized in the liver, with a half-life that supports once or twice daily dosing. The drug is primarily excreted via the kidneys, necessitating caution in patients with renal impairment.

Pregnancy

Data regarding the safety of this drug during pregnancy is limited. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised when administering this drug to breastfeeding mothers. The effects on the nursing infant are unknown.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.

Indications

• Bacterial infections
• Pneumonia
• Streptococcal infections
• Syphilis
• Meningitis
• Endocarditis
• Skin infections

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations based on the type of penicillin and indication.

Adults: Refer to the BNF for specific dosing recommendations based on the type of penicillin and indication.

Mechanism of action

Penicillin targets penicillin-binding proteins (PBPs) located inside the bacterial cell wall. By binding to these proteins, penicillin disrupts the transpeptidation process, which is essential for cell wall structural integrity. This results in weakened cell walls, causing osmotic instability and ultimately leading to cell lysis and death.

Pharmacodynamics

Penicillin exhibits bactericidal activity, meaning that it kills bacteria rather than merely inhibiting their growth. Its effectiveness is generally dependent on the growth phase of the bacteria, as it is most active against actively dividing cells. The spectrum of activity varies among different penicillins, with some being more effective against specific bacterial strains.

Pharmacokinetics

Penicillin is primarily absorbed in the gastrointestinal tract, with its bioavailability varying depending on the specific type of penicillin. It is primarily excreted by the kidneys, with a half-life that typically ranges from 30 minutes to 2 hours, depending on the formulation. Dosage adjustments may be necessary in patients with renal impairment to prevent accumulation and toxicity.

Contra-indications

• History of hypersensitivity to penicillins
• Severe allergic reactions to beta-lactam antibiotics

Adverse effects

• Allergic reactions such as rash, urticaria, and anaphylaxis
• Gastrointestinal disturbances including nausea, vomiting, and diarrhea
• Superinfection due to alteration of normal flora
• Hematologic reactions such as leukopenia, thrombocytopenia

Interactions

• valproate+penicillins: Severe (increases risk of adverse effects)
• allopurinol+penicillins: Unknown (increases risk of skin rash)
• leflunomide+penicillins: Unknown (increases exposure)
• nitisinone+penicillins: Unknown (increases exposure)
• penicillins+phenindione: Unknown (increases risk of bleeding events)
• teriflunomide+penicillins: Unknown (increases exposure)

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of allergic reactions
• Consider alternative therapy in patients with a history of severe allergies

Pregnancy

Penicillins are generally considered safe to use during pregnancy; however, consult local guidelines and assess benefits versus risks.

Breast-feeding

Penicillins are excreted in breast milk in small amounts; generally considered safe, but monitor infant for possible effects.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral tablets
• Oral suspension
• Intravenous injection
• Intramuscular injection

Dosage

Children: Refer to specific guidelines based on the actual medication intended or the therapeutic context.

Adults: Refer to specific guidelines based on the actual medication intended or the therapeutic context.

Mechanism of action

The specific mechanism of action for 'relatively' is not defined due to the vague nature of the term. However, medications that may fall under similar classifications typically exert their effects by modulating neurotransmitter levels, influencing receptor activity, or altering physiological pathways to achieve therapeutic outcomes.

Pharmacodynamics

Pharmacodynamics will vary based on the specific drug intended by the term 'relatively'. Generally, medications may work by interacting with specific receptors, inhibiting enzymes, or altering cellular signaling pathways, which can lead to desired therapeutic effects such as pain relief, anti-inflammatory effects, or other clinical benefits.

Pharmacokinetics

The pharmacokinetics of drugs that may be associated with the term 'relatively' can include absorption, distribution, metabolism, and excretion characteristics that are unique to each specific agent. Typically, factors such as bioavailability, volume of distribution, half-life, and clearance rates are critical for understanding the drug's behavior in the body.

Pregnancy

There is limited information on the safety of relatively during pregnancy. Caution is advised, and it should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether relatively is excreted in human breast milk. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Major depressive disorder
• Osteoarthritis
• Liver disease
• Cirrhosis
• Fibromyalgia
• Chronic pain

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations in paediatric patients.

Adults: Refer to the BNF for specific dosing recommendations based on the condition being treated.

Mechanism of action

SAMe functions primarily as a methyl donor in transmethylation reactions. It is synthesized from L-methionine and adenosine triphosphate (ATP) through the action of S-adenosylmethionine synthetase. By donating methyl groups, SAMe facilitates the biosynthesis of various biomolecules, including DNA, RNA, proteins, phospholipids, and neurotransmitters. This process is essential for cellular metabolism, growth, and repair.

Pharmacodynamics

SAMe is an intermediate metabolite of methionine, playing a critical role in methylation processes that are vital for cellular functions. It contributes to the maintenance of cellular structures, particularly the phospholipid bilayer of membranes. SAMe also influences the activity of hormones and neurotransmitters that are important for mood regulation, with its highest concentrations found in the brain and liver, where it supports neuronal health and function.

Pharmacokinetics

The pharmacokinetics of SAMe indicate that it is rapidly distributed throughout the body after administration. Its bioavailability can be affected by various factors, including the route of administration. SAMe is metabolized primarily in the liver, and its metabolites participate in various biochemical pathways, including the trans-sulfuration and one-carbon metabolism pathways. The elimination half-life of SAMe is relatively short, necessitating multiple doses for sustained effects.

Pregnancy

There are no adequate and well-controlled studies in pregnant women. SAMe should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether SAMe is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, protect from moisture and light.

Indications

• Motion sickness
• Nausea and vomiting associated with surgery
• Palliative care for excessive salivation
• Adjunct treatment for certain types of pain

Dosage

Children: Refer to the BNF for Children for appropriate dosing guidelines for paediatric patients.

Adults: Refer to the BNF for specific dosing recommendations based on the indication and patient factors.

Mechanism of action

Scaret acts as a competitive antagonist at muscarinic acetylcholine receptors. By inhibiting the action of acetylcholine in the central nervous system and peripheral tissues, it reduces the activity of the vestibular system, leading to decreased nausea and vomiting.

Pharmacodynamics

Scaret exhibits dose-dependent effects on the central nervous system and peripheral tissues. It decreases secretions in the respiratory tract and gastrointestinal tract, reduces smooth muscle spasms, and alters the perception of motion. The onset of action typically occurs within 30 minutes to 1 hour after administration, with effects lasting for several hours.

Pharmacokinetics

Scaret is well absorbed after transdermal administration and undergoes extensive first-pass metabolism in the liver. The bioavailability of the drug varies based on the route of administration. The peak plasma concentration is achieved within 1 to 3 hours, with a half-life of approximately 2 to 3 hours. Scaret is primarily excreted via the kidneys, with metabolites being eliminated in urine.

Pregnancy

There is insufficient data to determine the safety of Scaret in pregnancy. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

The excretion of Scaret in breast milk is unknown. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Pregnancy

Consult a healthcare provider. Safety during pregnancy has not been established.

Breast-feeding

Consult a healthcare provider. Safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Acute bacterial tonsillitis
• Chronic tonsillitis
• Peritonsillar abscess
• Symptomatic relief of sore throat

Dosage

Children: Refer to the BNF for Children for appropriate dosing guidelines based on age and weight.

Adults: Refer to the BNF for specific antibiotic dosing based on the causative organism and severity of infection.

Mechanism of action

In the case of bacterial tonsillitis, antibiotics such as penicillin act by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Other common treatments may include anti-inflammatory medications that reduce swelling and pain by inhibiting cyclooxygenase enzymes, thereby decreasing the production of prostaglandins.

Pharmacodynamics

The pharmacodynamics of antibiotics in tonsillitis involves the reduction of bacterial load, alleviating infection-associated symptoms. Analgesics and anti-inflammatories decrease the inflammatory response, providing symptomatic relief. The overall goal is to resolve the infection and reduce associated discomfort.

Pharmacokinetics

Antibiotics are generally well absorbed following oral administration, with peak plasma concentrations typically reached within a few hours. They are distributed throughout the body and can penetrate tissues, including the tonsils. The elimination half-life varies by drug, influencing dosing regimens. Analgesics have similar absorption profiles, with varying onset times depending on the specific agent used.

Pregnancy

Consult a healthcare provider for advice on the use of medications for tonsillitis during pregnancy, as safety varies depending on the specific drug used.

Breast-feeding

Consult a healthcare provider for advice on the use of medications for tonsillitis while breastfeeding, as safety varies depending on the specific drug used.

Storage

Store medications at room temperature, away from moisture and heat, and keep out of reach of children.

Mechanism of action

S-Adenosylmethionine (SAMe) is a natural substance present in the cells of the body. It is a direct metabolite of the essential amino acid L-methionine. SAMe plays a crucial biochemical role in the body by donating a one-carbon methyl group in a process called transmethylation. SAMe, formed from the reaction of L-methionine and adenosine triphosphate catalyzed by the enzyme S-adenosylmethionine synthetase, is the methyl-group donor in the biosynthesis of both DNA and RNA nucleic acids, phospholipids, proteins, epinephrine, melatonin, creatine and other molecules.

Pharmacodynamics

S-adenosylmethionine is an intermediate metabolite of methionine. Its involvement in methylation assists in cellular growth and repair, maintains the phospho-bilipid layer in cell membranes. It also helps in the maintenance of the action of several hormones and neurotransmitters that affect mood. Highest concentration are found in the brain and the liver.